title: Phase II trial of five day intravenous infusion vinblastine sulfate in patients with diffuse malignant mesothelioma: a Southwest Oncology Group study.
authors.forename: J D
authors.initials: JD
authors.lastname: Cowan
authors.forename: S
authors.initials: S
authors.lastname: Green
authors.forename: J
authors.initials: J
authors.lastname: Lucas
authors.forename: J K
authors.initials: JK
authors.lastname: Weick
authors.forename: S P
authors.initials: SP
authors.lastname: Balcerzak
authors.forename: S E
authors.initials: SE
authors.lastname: Rivkin
authors.forename: C A
authors.initials: CA
authors.lastname: Coltman
authors.forename: L H
authors.initials: LH
authors.lastname: Baker
mesh_terms: D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008654:Mesothelioma / Q000188:drug therapy*; D008875:Middle Aged; D015206:Southwestern United States; D013997:Time Factors; D014747:Vinblastine / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D014747:Vinblastine